- Issuer ticker
-
N/A
- Reported as of
-
22 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
3
- Accepted by SEC
-
22 Oct 2026, 19:15:04 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Amy Bachrodt, Attorney-in-Fact
Filing notes and source
Key filing fact
Steven Staben filed Form 3 for Lycia Therapeutics, Inc. on 22 Oct 2026.
Key facts
- This page summarizes Steven Staben's Form 3 filing for Lycia Therapeutics, Inc..
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2026, 19:15.
Change
- Previous filing in this sequence was filed on 26 Oct 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0002159565
Primary reporting owner
Staben Steven
- Relationship
-
Chief Scientific Officer, 10%+ Owner
- Address
- C/O LYCIA THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO
- Signature
- /s/ Amy Bachrodt, Attorney-in-Fact
- Signature date
- 22 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 55,448
- Date
- 22 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 22 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 166,345
- Exercise price
- $1.63
- Footnotes
- F1
No ticker
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 22 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 155,255
- Exercise price
- $2.44
- Footnotes
- F2
No ticker
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 22 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,179
- Exercise price
- $2.35
- Footnotes
- F3
No ticker
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 22 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 110,896
- Exercise price
- $3.70
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Explanation of responses
4 footnotes